Picture [iito] Männer Ballett 650x80px
Collaboration › Details

Invitae–JPMorgan Chase: investor conference, 202101 supply service Invitae presents at JP Morgan Healthcare Conference 2021


Period Period 2021-01-13
Organisations Partner, 1st Invitae Corporation (NYSE: NVTA)
  Group Invitae (Group)
  Partner, 2nd J.P. Morgan Securities LLC
  Group JPMorgan Chase (Group)
Products Product J.P. Morgan 39th Annual Healthcare Conference 2021 DIGITAL
  Product 2 genetics
Persons Person George, Sean Emerson (Invitae 201911 CEO + Co-Founder before Loocus Development + Navigenics + Affymetrix)
  Person 2 D’Angelo, Laura (Invitae 202012 Investor Relations)

Invitae Corporation. (12/29/20). "Press Release: Invitae to Present at the 39th Annual J.P. Morgan Healthcare Conference". San Francisco, CA.

Invitae Corporation (NYSE: NVTA), a leading medical genetics company, today announced that Sean George, co-founder and chief executive officer of Invitae, will present at the 39th Annual J.P. Morgan Healthcare Conference on Tuesday, January 12, 2021 at 10:50 a.m. Eastern/7:50 a.m. Pacific. Following the company presentation, management will participate in a virtual breakout session at 11:10 a.m. Eastern/8:10 a.m. Pacific.

Invitae's (NVTA) mission is to bring comprehensive genetic information into mainstream medical practice to improve the quality of healthcare for billions of people. (PRNewsFoto/Invitae Corporation)

The 2021 J.P. Morgan Healthcare Conference is being held virtually via webinar. A live webcast of both the presentation and the breakout session may be accessed at the following direct link or by visiting the investors section of the company's website at

Public listeners can access an audio and slide recording of the session, which will be available shortly after the conclusion of the presentation and breakout session on the investors section of the company's website at

About Invitae

Invitae Corporation (NYSE: NVTA) is a leading medical genetics company whose mission is to bring comprehensive genetic information into mainstream medicine to improve healthcare for billions of people. Invitae's goal is to aggregate the world's genetic tests into a single service with higher quality, faster turnaround time, and lower prices. For more information, visit the company's website at

Laura D'Angelo
(628) 213-3369

Record changed: 2020-12-29


Picture [iito] No Content Marketing 650x80px

More documents for Invitae (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Picture EBD Group BioTech Showcase 2021 Digital Event BTS2021 651x81

» top